Gentibio, Inc
Clinical trials sponsored by Gentibio, Inc, explained in plain language.
-
Scientists test One-Time cell injection to fight diabetes
Disease control Recruiting nowThis is a very early safety study testing a one-time, personalized cell therapy called GNTI-122 in adults recently diagnosed with type 1 diabetes. The therapy is made from a patient's own blood cells and aims to help the body better control blood sugar. Researchers will monitor 1…
Phase: PHASE1 • Sponsor: GentiBio, Inc • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists seek genetic clues in new type 1 diabetes patients
Knowledge-focused Recruiting nowThis study aims to understand how often a specific gene variant (HLA-DRB1*04:01) appears in adults recently diagnosed with type 1 diabetes. Researchers will enroll 50 participants aged 18-45 who were diagnosed within the last 2 months. The study involves a single blood draw to an…
Sponsor: GentiBio, Inc • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC